FDA to Host Public Meeting on Evaluating Inclusion and Exclusion Criteria in Clinical Trials

Summary

The FDA is convening a public meeting to discuss the eligibility criteria in clinical trials and their impact on patient access to investigational drugs, with the goal of facilitating a diverse patient population.